Alexander Scharmann, DPT, OCS | |
47 Doc Perkes Rd, Afton, WY 83110 | |
(307) 883-8877 | |
(307) 883-8876 |
Full Name | Alexander Scharmann |
---|---|
Gender | Male |
Speciality | |
Experience | Years |
Location | 47 Doc Perkes Rd, Afton, Wyoming |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1164805123 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | PT-4243 (Idaho) | Secondary |
225100000X | Physical Therapist | 3392 (Nebraska) | Secondary |
225100000X | Physical Therapist | PT-1776 (Wyoming) | Primary |
Mailing Address | Practice Location Address |
---|---|
Alexander Scharmann, DPT, OCS Po Box 860, Thayne, WY 83127-0860 Ph: (307) 883-8877 | Alexander Scharmann, DPT, OCS 47 Doc Perkes Rd, Afton, WY 83110 Ph: (307) 883-8877 |
News Archive
Chronic wasting disease (CWD) — an infectious disease caused by prions — affects North American elk and deer, but has not been observed in humans. Using a mouse model that expresses an altered form of the normal human prion protein, researchers at University of California, San Diego School of Medicine have determined why the human proteins aren't corrupted when exposed to the elk prions.
Lignol Energy Corporation, a leading technology company in the advanced biofuels and renewable chemicals sector, today announced its financial results for the year ended April 30, 2013 (all figures in Canadian dollars, unless otherwise noted).
We live in a world invaded by plastic. Its role as a chemically stable, versatile and multi-purpose fostered its massive use, which has finally translated into our current situation of planetary pollution.
N30 Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on the development of product candidates for cystic fibrosis (CF), announced today that the Company has changed its name to Nivalis Therapeutics, Inc. The Company's lead product candidate, N91115, is a novel inhibitor of S-nitrosoglutathione reductase (GSNOR).
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain today announced that it has received CE Mark approval (Conformite Europeenne) for the Zalviso device.
› Verified 9 days ago
Korry Wheeler, PT, DPT, ECS Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 901 Adams St, Afton, WY 83110 Phone: 307-883-7878 | |
Jared Andrew Rose, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 N Washington, Afton, WY 83110 Phone: 307-885-4278 Fax: 307-885-4270 | |
Jessica Draney Hall, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 67 Doc Perkes, Afton, WY 83110 Phone: 307-885-7878 | |
Matthew David Harris, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 901 Adams St, Afton, WY 83110 Phone: 307-885-5800 Fax: 307-885-5865 | |
Dr. Cache D Kennington, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 67 Doc Perkes, Afton, WY 83110 Phone: 307-883-7878 | |
Allred Performance And Rehabilitation Llc Physical Therapist Medicare: Medicare Enrolled Practice Location: 533 Allred Rd, Afton, WY 83110 Phone: 307-877-6206 |